136 related articles for article (PubMed ID: 24434139)
1. TMPRSS4 induces cancer cell invasion through pro-uPA processing.
Min HJ; Lee MK; Lee JW; Kim S
Biochem Biophys Res Commun; 2014 Mar; 446(1):1-7. PubMed ID: 24434139
[TBL] [Abstract][Full Text] [Related]
2. TMPRSS4 upregulates uPA gene expression through JNK signaling activation to induce cancer cell invasion.
Min HJ; Lee Y; Zhao XF; Park YK; Lee MK; Lee JW; Kim S
Cell Signal; 2014 Feb; 26(2):398-408. PubMed ID: 23978400
[TBL] [Abstract][Full Text] [Related]
3. TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.
Lee Y; Ko D; Min HJ; Kim SB; Ahn HM; Lee Y; Kim S
Oncotarget; 2016 Aug; 7(31):50315-50332. PubMed ID: 27385093
[TBL] [Abstract][Full Text] [Related]
4. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.
Jung H; Lee KP; Park SJ; Park JH; Jang YS; Choi SY; Jung JG; Jo K; Park DY; Yoon JH; Park JH; Lim DS; Hong GR; Choi C; Park YK; Lee JW; Hong HJ; Kim S; Park YW
Oncogene; 2008 Apr; 27(18):2635-47. PubMed ID: 17968309
[TBL] [Abstract][Full Text] [Related]
5. TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways.
Kim S; Kang HY; Nam EH; Choi MS; Zhao XF; Hong CS; Lee JW; Lee JH; Park YK
Carcinogenesis; 2010 Apr; 31(4):597-606. PubMed ID: 20118200
[TBL] [Abstract][Full Text] [Related]
6. Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA.
Owen KA; Qiu D; Alves J; Schumacher AM; Kilpatrick LM; Li J; Harris JL; Ellis V
Biochem J; 2010 Feb; 426(2):219-28. PubMed ID: 20015050
[TBL] [Abstract][Full Text] [Related]
7. TMPRSS4 promotes invasiveness of human gastric cancer cells through activation of NF-κB/MMP-9 signaling.
Jin J; Shen X; Chen L; Bao LW; Zhu LM
Biomed Pharmacother; 2016 Feb; 77():30-6. PubMed ID: 26796262
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of TMPRSS4 mediated epithelial-mesenchymal transition is critically involved in antimetastatic effect of melatonin in colorectal cancers.
Oh BS; Im E; Lee HJ; Sim DY; Park JE; Park WY; Park Y; Koo J; Pak JN; Kim DH; Shim BS; Kim SH
Phytother Res; 2021 Aug; 35(8):4538-4546. PubMed ID: 34114707
[TBL] [Abstract][Full Text] [Related]
10. Serase-1B, a new splice variant of polyserase-1/TMPRSS9, activates urokinase-type plasminogen activator and the proteolytic activation is negatively regulated by glycosaminoglycans.
Okumura Y; Hayama M; Takahashi E; Fujiuchi M; Shimabukuro A; Yano M; Kido H
Biochem J; 2006 Dec; 400(3):551-61. PubMed ID: 16872279
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase epsilon/PRSS22.
Yasuda S; Morokawa N; Wong GW; Rossi A; Madhusudhan MS; Sali A; Askew YS; Adachi R; Silverman GA; Krilis SA; Stevens RL
Blood; 2005 May; 105(10):3893-901. PubMed ID: 15701722
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells.
Simeone AM; Nieves-Alicea R; McMurtry VC; Colella S; Krahe R; Tari AM
Int J Oncol; 2007 Apr; 30(4):785-92. PubMed ID: 17332916
[TBL] [Abstract][Full Text] [Related]
13. TMPRSS4 Upregulates TWIST1 Expression through STAT3 Activation to Induce Prostate Cancer Cell Migration.
Jianwei Z; Qi L; Quanquan X; Tianen W; Qingwei W
Pathol Oncol Res; 2018 Apr; 24(2):251-257. PubMed ID: 28466252
[TBL] [Abstract][Full Text] [Related]
14. Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism.
Botkjaer KA; Deryugina EI; Dupont DM; Gårdsvoll H; Bekes EM; Thuesen CK; Chen Z; Ploug M; Quigley JP; Andreasen PA
Mol Cancer Res; 2012 Dec; 10(12):1532-43. PubMed ID: 23038812
[TBL] [Abstract][Full Text] [Related]
15. Pro-urokinase-type plasminogen activator is a substrate for hepsin.
Moran P; Li W; Fan B; Vij R; Eigenbrot C; Kirchhofer D
J Biol Chem; 2006 Oct; 281(41):30439-46. PubMed ID: 16908524
[TBL] [Abstract][Full Text] [Related]
16. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.
Biliran H; Sheng S
Cancer Res; 2001 Dec; 61(24):8676-82. PubMed ID: 11751384
[TBL] [Abstract][Full Text] [Related]
17. TMPRSS4: an emerging potential therapeutic target in cancer.
de Aberasturi AL; Calvo A
Br J Cancer; 2015 Jan; 112(1):4-8. PubMed ID: 25203520
[TBL] [Abstract][Full Text] [Related]
18. Polyserase-1/TMPRSS9 induces pro-tumor effects in pancreatic cancer cells by activation of pro-uPA.
Fontanil T; Mohamedi Y; Esteban MM; Obaya AJ; Cal S
Oncol Rep; 2014 Jun; 31(6):2792-6. PubMed ID: 24756697
[TBL] [Abstract][Full Text] [Related]
19. TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.
de Aberasturi AL; Redrado M; Villalba M; Larzabal L; Pajares MJ; Garcia J; Evans SR; Garcia-Ros D; Bodegas ME; Lopez L; Montuenga L; Calvo A
Cancer Lett; 2016 Jan; 370(2):165-76. PubMed ID: 26546046
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells.
Cavallo-Medved D; Mai J; Dosescu J; Sameni M; Sloane BF
J Cell Sci; 2005 Apr; 118(Pt 7):1493-503. PubMed ID: 15769846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
